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Abstract
Replication and transcription activator (RTA), mostly encoded by Kaposi’s sarcoma-associated herpesvirus (KSHV) open reading frame
50, is expressed in the immediate-early phase of reactivation and plays a critical role in inducing the viral lytic cycle in KSHV-infected cells.
We established cell clones from BJAB cells and replication-deficient BCBL-1 cells in which KSHV RTA expression was controlled by an
inducible promoter of the tetracycline-based Tet-Off expression system. In RTA-inducible BJAB cells, tetracycline removal induced the
synthesis of RTA, resulting in cell death. DNA fragmentation, structural changes in the cell membrane, and poly(ADP-ribose) polymerase
(PARP) cleavage were observed in the RTA-induced BJAB cells, indicating that RTA expression induced caspase activation and cell death
by apoptosis. However, expression of RTA in RTA-inducible BCBL-1 cells did not undergo apoptosis and cell death. These results
suggested that KSHV RTA is an apoptosis inducer that is opposed by an antiapoptotic pathway in infected cells.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Kaposi’s sarcoma-associated herpesvirus (KSHV), also
designated human herpesvirus 8 (HHV-8), was discovered
in Kaposi’s sarcoma (KS) (Chang et al., 1994), the most
common AIDS-related malignancy. KSHV DNA is found
in most cases in both AIDS-related and classical KS lesions
(Schulz, 1998). Moreover, KSHV is also involved in the
pathogenesis of multicentric Castleman’s disease (MCD)
(Soulier et al., 1995), and primary effusion lymphoma
(PEL) (Cesarman et al., 1995a), suggesting that KSHV
could be an oncogenic DNA virus. Based on sequence
analyses (Russo et al., 1996), KSHV is classified as a new
member of the gammaherpesvirus subfamily and has ge-
netic similarity to herpesvirus saimiri (HVS), murine gam-
maherpesvirus 68 (MHV68), and Epstein–Barr virus
(EBV), which are also thought to be oncogenic viruses
(Efstathiou et al., 1990; Moore et al., 1996).
Several KSHV-infected cell lines have been established
from PELs: the BC-1 cell line, which is coinfected with both
EBV and KSHV (Cesarman et al., 1995b; Gaidano et al.,
1996), and the BCBL-1 cell line, which is positive for
KSHV but not EBV (Arvanitakis et al., 1996; Renne et al.,
1996). Similar to the other gammaherpesviruses (zur
Hausen et al., 1978), KSHV can be induced to undergo lytic
replication by chemical agents such as 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) and n-butyrate, in these cell lines
(Miller et al., 1997; Yu et al., 1999).
Induction of the viral lytic cycle, which involves viral
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DNA replication and the release of virions, results in cell
death in almost all cases, due to massive viral amplification
followed by the destruction of cellular survival mecha-
nisms. In the case of adenovirus, expression of an early
gene, E1A, causes p53 induction, which leads to apoptosis
(programmed cell death), and another early gene, E1B,
antagonizes this process by inhibiting p53 activity and func-
tioning as a Bcl-2-like molecule. Thus, the regulation of cell
death is important for viral replication (Debbas and White,
1993). Consistent with this, herpes simplex virus type 1
(HSV-1) can induce or inhibit apoptosis in a cell type
dependent manner (Galvan and Roizman, 1998), and KSHV
has many genes that have pro- and antiapoptotic function
(Cheng et al., 1997; Ojala et al., 1999; Belanger et al., 2001;
Seo et al., 2001; Feng et al., 2002).
Immediate-early (IE) genes have a critical role in bring-
ing about lytic replication. These genes, most of which
encode regulatory proteins that alter the expression of viral
and cellular genes, are the first class of viral genes expressed
after primary infection or reactivation. Their expression
leads to the upregulation of early and late genes and matu-
ration of the virus particle. KSHV replication and transcrip-
tion activator (RTA) is expressed very early (4 h) in
reactivation, prior to the other lytic genes (Sun et al., 1998;
Lukac et al., 1999). Recent analyses have shown that the
expression of the RTA gene, and not the K8 gene, can
induce the viral lytic cycle in KSHV-infected cell lines
(Lukac et al., 1999; Chen et al., 2000; Gradoville et al.,
2000), and we reported that induction of some lytic gene
expression and viral replication were markedly reduced in
an RTA-depressed cell line that we had subcloned from
BCBL-1 cells (Nishimura et al., 2001).
In this study, we established conditional RTA-expressing
systems in both KSHV-infected and uninfected cells and
used them to investigate the function of RTA. We found that
RTA expression led to apoptosis induction in uninfected
cells (BJAB) but not in infected cells (BCBL-1 and BC-3).
These results suggest that RTA could be, not an apoptosis
blocker, but an inducer like adenoviral E1A, and in infected
cells, various gene products protect against this process to
enable efficient viral amplification.
Results
Isolation of stable BJAB cell clones that inducibly
produce KSHV RTA
To investigate the function of the viral transcriptional
activator encoded by KSHV ORF50 (RTA), we sought to
isolate cell lines that conditionally express RTA. First, we
transfected cell lines with an RTA-expression vector many
times (pcDNA3.1-ORF50-cDNA), followed by G418 selec-
tion to establish a stably RTA expressing cell line. How-
ever, no clones were obtained after the selection after all,
perhaps because of the toxicity of the stable expression of
RTA. Therefore, we used the artificial transcriptional regu-
lation system developed by Gossen and Bujard. In this
system, the presence of tetracycline (tet) in the culture
medium prevents a chimeric transactivator (tetracycline-
responsive transcriptional activator, tTA) from binding to a
synthetic promoter, while the removal of tet induces the
transcription of the gene placed under the control of this
promoter within a few hours (Gossen and Bujard, 1992).
Several KSHV-infected cell lines that have been established
from PELs are genotypically B cells with their immuno-
globulin gene rearrangement (Drexler et al., 1998); there-
fore, we chose to use BJAB cells, EBV-negative Burkitt’s
lymphoma cells, to establish cells expressing RTA under
control of the Tet-Off system. In these cells, the other
KSHV genes were ignored.
We first established cell lines that stably expressed tTA
(BJAB/off) by the Rev/Tet system (Clontech) and then
introduced the RTA gene under control of a promoter with
a Tet-responsive element (TRE) (Fig. 1A), as described
under Materials and methods. After selection and cell clon-
ing, 28 clones that were resistant to both G418 and hygro-
mycin were screened for the conditional expression of RTA
by IFA, and 6-positive clones were isolated. Among these,
the clone named BJAB/off  RTA-27 showed the highest
induction of RTA, so we used this clone in subsequent
experiments.
RTA expression induces cell death
A highly regulated expression of RTA was observed 12 h
postinduction in BJAB/off  RTA-27 cells by Western
blotting using a specific antibody against RTA, and there
was no background RTA expression seen in uninduced cells
subjected to the same analysis (Fig. 1B). RTA expression
was observed in almost all the cells by immunofluorescence
assay (IFA), although the level of expression varied (data
not shown). After RTA induction by the removal of tet from
the culture medium, no morphological change was apparent
within a few days, but a decrease in the number of live cells
was observed a week after induction (data not shown). To
determine whether cell death was induced in the RTA-
expressing cells, we examined the cells microscopically
with trypan blue staining and calculated the cell viability.
As shown in Fig. 2A, cell death started 3 days postinduc-
tion, and the viability decreased to less than 50% 1 week
later, while the cells without RTA induction were almost all
viable. Similar results were obtained for the other BJAB/off
 RTA clones, but not BJAB/off  TRE cells, in which
only TRE (Fig. 1A) was introduced instead of TRE-RTA
(data not shown).
These findings indicated that cell death was induced
by RTA expression in BJAB cells a few days after in-
duction.
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RTA expression induces cell death by apoptosis
mechanism
To examine the cell death that was induced in RTA-
expressing BJAB/off  RTA-27 cells, we tested for inter-
nucleosomal DNA fragmentation by the terminal deoxynu-
cleotidyl-transferase-mediated dUTP nick-end labeling
(TUNEL) assay (Gavrieli et al., 1992). BJAB/off 
RTA-27 cells with or without induction of RTA expression
were harvested at different times and subjected to flow
cytometric analysis as indicated under Materials and meth-
ods. The analysis clearly showed that DNA fragmentation
occurred in the RTA-induced BJAB/off  RTA-27 cells 6
days postinduction (Fig. 3A), whereas no change was ob-
served in uninduced BJAB/off RTA-27 cells, even 8 days
postinduction (data not shown). These results suggested that
the RTA-induced death of BJAB/off  RTA-27 cells was
caused by an apoptosis mechanism.
To further demonstrate that programmed cell death oc-
curs in RTA-induced BJAB/off  RTA-27 cells, we ana-
lyzed the structural changes in the cell membrane. It is
known that, soon after apoptosis, the membrane phosphati-
dyl-serine (PS) is translocated from the inner face of the
plasma membrane to the outer surface. PS on the cell sur-
face can be detected by Annexin V, which has a high
affinity for it (Martin et al., 1995). Furthermore, propidium
iodide (PI) does not penetrate cells in the early phase of
apoptosis, but does in the late phase because of destruction
of the cell membrane. As shown in Fig. 3C, the structural
change had occurred in the membrane of RTA-induced
BJAB/off  RTA-27 cells 4 days postinduction, and PI did
not stain the cells at that time, but did 6 days postinduction
(data not shown). These results suggest that 4 days after
induction the cells were mostly in the early phase of
apoptosis and by 6 days were mostly in the later phase, and
that the RTA-induced cell death is caused by a canonical
apoptosis mechanism.
In recent years, many of the molecules that participate in
the highly ordered process of apoptotic cell suicide have
been unveiled. The family of cysteine proteases known as
caspases plays an essential role in apoptosis (Nicholson and
Thornberry, 1997; Salvesen and Dixit, 1997). Caspases
cleave several key structural cellular components, leading to
the systematic and ordered disassembly of the dying cell.
One of the best characterized caspase substrates is poly-
(ADP-ribose) polymerase (PARP), a nuclear protein in-
volved in DNA repair (Wang et al., 1997). We observed by
Western blotting that PARP was cleaved in the RTA-in-
duced BJAB/off  RTA-27 cells 4 days postinduction, but
not in uninduced cells (Fig. 3E). This result suggested that
caspases were activated in the RTA-induced BJAB/off 
RTA-27 cells.
Taken together, the results from the TUNEL assay, An-
nexin V, PI staining, and Western blotting for PARP indi-
cated that the expression of KSHV RTA induced the acti-
vation of a caspase signaling pathway, and as a result, the
RTA-induced BJAB/off  RTA-27 cells died of apoptosis.
Fig. 1. Generation of stable BJAB clones that inducibly synthesize RTA. (A) Structure of retroviral vectors that contain the Tet-responsive element (TRE).
TRE contains sevendirect repeats of the 42-bp tetO operator sequence, upstream of a minimal CMV promoter, which can be bound by the tTA transactivator:
pRev-TRE is a control vector. pRev-TRE-RTA was constructed by inserting RTA cDNA into the HpaI site of pRev-TRE. (B) RTA expression in BJAB/off
 RTA-27 cells. Whole-cell extracts were obtained at different time points postinduction (Tc[]) and analyzed by Western blotting using specific antibodies
against RTA. The same amount of total protein (20 g) was loaded in each lane. The positions of molecular mass markers are shown on the left. The arrow
indicates RTA protein.
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Isolation of RTA-inducible KSHV-infected cells
Since chemical agents, such as TPA and n-butyrate, that
are used to induce lytic replication, can stimulate not only
RTA expression but also many cellular and viral signaling
pathways, we could not assess whether RTA expression
induces the apoptosis in KSHV-infected cell lines, such as
BCBL-1, BC-1, and BC-3. Therefore, we next tried to
isolate cell clones from KSHV-infected cell lines, in which
the RTA expression is regulated by the Tet-Off system, as
in the BJAB/off  RTA-27 cells.
RTA protein is necessary and sufficient to drive the lytic
cycle (Lukac et al., 1999; Nishimura et al., 2001), and RTA
expression induces viral DNA replication and the release of
mature viral particles that are toxic for host cells. We won-
dered if the apoptosis caused by RTA could not be distin-
guished from that due to viral proliferation. Recently, we
reported that by subcloning BCBL-1 cells we isolated three
RTA-depressed clones that did not respond to TPA induc-
tion and could not enter viral replication (Nishimura et al.,
2001). From such subcloning, we also obtained replication-
deficient clones. In one of these clones, the expression of
immediate-early and early genes, for example the vIRF
gene, were induced as in the parental BCBL-1 cells, but late
genes, such as the K8.1 gene, were not induced (Fig. 4A) As
a result, neither viral DNA replication (Fig. 4B) nor the
release of viral particles (data not shown) took place in these
replication-deficient cells. Thus, we used these replication-
deficient KSHV-infected cells to create cells expressing
RTA under the Tet-Off system and to exclude the effect of
viral replication and particle production on the analysis of
apoptosis induction by RTA.
We infected the replication-deficient BCBL-1 cells with
a tTA-encoding retrovirus, followed by a TRE-RTA-encod-
ing one, as the methods for creation of RTA-inducible
BJAB clones, and isolated 24 clones that were resistant to
both G418 and hygromycin. Among these, six positive
clones were isolated by screening the induction of RTA
with IFA, and of these, the one named BCBL-1/off 
RTA-2 showed the highest induction of RTA, so we used
this clone in the subsequent experiments.
RTA expression induced other viral gene expression
Very low background and highly induced RTA expres-
sion was observed in the BCBL-1/off  RTA-2 cells by
Western blotting (Fig. 4C). First, we assessed the induction
of lytic gene expression followed by the RTA expression.
As shown in Fig. 5, RTA induction by the removal of tet
from the culture medium led to the expression of many lytic
genes in BCBL-1/off RTA-2 cells, similar to the effect of
TPA. However, these did not include late genes because the
parental BCBL-1 cells were replication-deficient cells in
which no late gene expression was observed by TPA induc-
tion. This induction of early gene expression by RTA agreed
with previous reports from other groups and ourselves (Sun
et al., 1998; Lukac et al., 1999; Nishimura et al., 2001).
RTA expression did not result in apoptosis in KSHV-
infected cells
In BJAB cells, RTA expression resulted in apoptosis. We
next tested whether apoptosis or another type of cell death
occurred in RTA-induced BCBL-1/off  RTA-2 cells. As
shown in Fig. 2B, RTA expression did not induce cell death,
and RTA-induced BCBL-1/off  RTA-2 cells grew as well
as uninduced ones. The other RTA-inducible BCBL-1
clones also grew as well as uninduced cells (data not
shown). Furthermore, the TUNEL assay (Fig. 3B), Annexin
V (Fig. 3D), PI staining (data not shown), and Western
blotting for PARP cleavage (Fig. 3F) were all negative in
the RTA-induced BCBL-1/off  RTA-2 cells. We contin-
ued to examine the cells until 13 days postinduction, but no
change was observed (data not shown).
These results suggest that RTA has an apoptosis-induc-
ing activity, and that some antiapoptotic mechanism is
Fig. 2. Cell viability of RTA-induced cells. Induced (closed circles) or
uninduced (closed squares) cells were collected at the indicated times and
stained with trypan blue, followed by observation by microscopy. Cell
viability was calculated by counting live and dead cells. A total of almost
300 cells was counted in each case. The points represent the average and
the bars show the standard deviation (SD) of three independent transfec-
tions. (A) BJAB/off  RTA-27, (B) BCBL-1/off  RTA-2.
67K. Nishimura et al. / Virology 316 (2003) 64–74
68 K. Nishimura et al. / Virology 316 (2003) 64–74
present in KSHV-infected cells, but not in uninfected BJAB
cells, which originate from the B-cell linage as do the
PEL-derived BCBL-1 cells.
Discussion
In this article, we showed that KSHV RTA induced
apoptosis in a B -cell line, and that the apoptotic pathway
was interrupted in KSHV-infected cells. The apoptosis-
inducing anti-Fas antibody can induce apoptosis within a
few hours (Ashkenazi and Dixit, 1998). KSHV v-cyclin also
induces apoptosis when it is transfected into human osteo-
sarcoma cell lines and other cells (Ojala et al., 1999); this
apoptosis is detected almost 2 days posttransfection. It took
more than 4 days for RTA to induce apoptosis, while RTA
expression itself was observed 12 h postinduction, suggest-
ing that the apoptosis induced by RTA expression in unin-
fected cells and by KSHV v-cyclin takes place by an indi-
rect mechanism, which is stimulated by the stepwise
activation of some endogenous cell-suicide genes. RTA is a
viral transactivator that triggers the expression of other lytic
genes and promotes viral replication ation (Sun et al., 1998;
Lukac et al., 1999; Nishimura et al., 2001). RTA is known
to upregulate viral gene expression that is both dependent
on and independent from specific DNA-binding activity
(Lukac et al., 2001; Song et al., 2001; Liang et al., 2002;
Ueda et al., 2002). Thus, it is thought that the transcription
of several cellular genes is upregulated by RTA expression
to produce the equipment needed for viral replication, and it
is possible that one of these genes results in the induction of
apoptosis, as seen in the BJAB cells, though such genes
have not been identified yet. The observation of PARP
cleavage in these cells suggested that the apoptosis induced
by RTA occurred through a caspase-dependent pathway
(Nicholson and Thornberry, 1997; Salvesen and Dixit,
1997).
Gwack et al. reported that RTA represses the transcrip-
tional activity of p53 and p53-induced apoptosis through
interaction with CREB-binding protein (CBP) (Gwack et
al., 2001). However, the conditional expression of RTA in
BJAB/off  RTA-27 and BCBL-1/off  RTA-2 cells did
not lead to p53 induction (data not shown), and recent
reports show that the KSHV K8 gene product (K-bZip),
whose expression is regulated by RTA, induces G1/S arrest
without p53 induction (Wu et al., 2002; Wang et al., 2003).
Thus, it is unlikely that a p53-dependent apoptosis pathway
was involved in the KSHV-infected cells. Rather, we think
it likely that RTA upregulates some other cellular gene
expression that is involved in apoptosis and turns on caspase
activity in a p53-independent manner.
KSHV has many genes that have an antiapoptotic func-
tion, such as KS-bcl-2, v-FLIP, vIRF, and K7 (Cheng et al.,
1997; Belanger et al., 2001; Seo et al., 2001; Feng et al.,
2002). Such gene products might oppose the cell death
induced by RTA during viral replication. Since RTA in-
duces the expression of a number of lytic genes, these
proteins are expressed under an RTA-induced condition,
and they could coordinately interrupt the apoptotic signal
induced by RTA. Recently, we observed that KSHV ORF57
might induce the expression of the antiapoptotic protein
XIAP through an IRES-dependent mechanism (K. Nish-
imura et al., submitted for publication). Thus, XIAP may be
an antiapoptotic factor opposing the RTA-induced apopto-
sis.
In summary, we showed that RTA was rather a potent
apoptosis inducer, apoptosis by which was executed in
uninfected cells, but not in replication-incompetent KSHV-
infected cells, where the KSHV immediate-early and early
genes were expressed normally. These cell lines will be
useful for clarifying what gene expressions are controlled
by RTA, which will be investigated using DNA chip anal-
ysis. We have also tried to isolate RTA-inducible cell lines
from replication-competent KSHV-infected cell lines. Such
a clone may be used in studies to assess the effect of RTA
expression on viral replication and late gene expression and
may enable us to obtain cell-free virus particles without
using chemical reagents such as TPA.
Materials and methods
Cell culture
BJAB cells and clones from BJAB cells [BJAB/off and
BJAB/off  RTA (see below)] were grown in RPMI 1640
medium supplemented with 10% heat-inactivated fetal bo-
vine serum (FBS) and other reagents, G418, hygromycin,
and tet, when they were needed, and BCBL-1 cells and
clones from BCBL-1 cells [BCBL-1/off and BCBL-1/off 
RTA (see below)] were grown with 20% heat-inactivated
FBS. RetroPack PT67 packaging cells (Clontech) were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% heat-inactivated FBS.
Fig. 3. RTA-induced apoptosis in BJAB cells, but not BCBL-1 cells. (A, B) Detection of DNA fragmentation in BJAB/off  RTA-27 (A) and BCBL-1/off
 RTA-2 (B) cells by theTUNEL assay. RTA-induced cells were collected at the indicated times postinduction and stained as described under Materials and
methods. Labeled cells (bold line) were analyzed by flow cytometry using unstained cells (dashed line) as a control. (C, D) Detection of structural changes
in the cell membrane of BJAB/off  RTA-27 (C) and BCBL-1/off  RTA-2 (D) by Annexin V staining. Fluorescence from the FITC-Annexin V of induced
(bold line) and uninduced (dashed line) cells was detected by flow cytometry. (E, F) Cleavage of poly(ADP-ribose) polymerase (PARP) in BJAB/off 
RTA-27 (E) and BCBL-1/off  RTA-2 (F) cells. Cells harvested at different times postinduction were treated and analyzed by SDS–PAGE and Western
blotting as indicated under Materials and methods. Full-length PARP (*) and the larger cleavage product (**) were detected by the same monoclonal antibody
against PARP. The positions of molecular mass markers are shown on the left.
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To induce the expression of RTA, cells grown in medium
containing 0.1 g/ml tet were collected and washed twice
with phosphate-buffered saline (PBS), and then cultured in
medium with (uninduced) or without (induced) 0.1 g/ml
tet.
Lytic gene expression was occasionally induced by treat-
ment with TPA at 25 ng/ml in some cases.
To investigate cell viability, the cells were stained with
0.04% trypan blue in PBS, followed by observation under a
microscope, and live and dead cells were counted. Viability
was expressed as (live cell number)/(live cell number plus
dead cell number)  100 (%).
Plasmids
pcDNA3.1-ORF50-cDNA, described previously (Chen
et al., 2000), which encodes the full-length RTA protein
with a myc-epitope and a (His)6-tag at the carboxy-termi-
nus, was digested with PmeI, and the fragment containing
the RTA cDNA sequence was inserted into the HpaI site of
the pRev-TRE (Clontech). The resultant plasmid, named
pRev-TRE-RTA, was used for the generation of RTA-in-
ducible cells.
Establishment of clones that inducibly produce RTA
For the isolation of stable RTA-inducible cells, we used
the RevTet-Off system (Clontech), which combines retro-
virus-mediated gene transfer with the tetracycline-regulated
control of the Tet-Off system. We first established BJAB
cells that stably expressed tTA. RetroPack PT67 packaging
cells (Clontech) were transfected with pRevTet-Off (Clon-
tech), and the G418-resistant (0.5 mg/ml) clones were iso-
lated. Titers of the virus produced from the G418-resistant
PT67 cell clones were determined by infection of NIH3T3
cells. BJAB cells were infected with tTA-encoding retrovi-
ruses collected from PT67 cells producing high titers of
virus. BJAB/off cell clones that stably express tTA were
selected with medium containing G418 (0.8 mg/ml) and
isolated in RPMI 1640 supplemented with 20% FBS and
1.5% methylcellulose no. 4000. To test for inducibility, the
BJAB/off cells were transiently infected with virus encod-
ing TRE-Luc, the luciferase gene driven by TRE, and the
luciferase activity in the induced and uninduced cells was
compared using the luciferase assay system (Promega).
Next, BJAB/off cell clones that showed higher inducibil-
ity were infected with the TRE-RTA-encoding retroviruses
produced from a PT67 cell clone that was stably transfected
with pRev-TRE-RTA. Positive cells were selected with 0.4
mg/ml hygromycin and 1.0 g/ml tet and cloned. G418- and
hygromycin-resistant clones (BJAB/off  RTA) were
screened for the inducibility of RTA expression by IFA
using specific monoclonal antibodies against RTA. Tet was
present at 1.0 g/ml during clone selection, but its concen-
tration was reduced to 0.1 g/ml for maintenance. This
lower tetracycline concentration allowed a much more rapid
induction of the RTA gene, without increasing its basal
expression level.
BCBL-1 cell clones in which stable RTA expression was
regulated by the Tet-Off system (BCBL-1/off RTA) were
established in the same way as the BJAB/off  RTA cells.
Cells that contained only TRE instead of TRE-RTA were
similarly established and used as a control.
Immunofluorescence assay (IFA)
At the selected time after induction, the cells were har-
vested, washed twice with PBS, spotted onto glass slides,
air-dried, and fixed with acetone:methanol (50:50) for 10
min at 20°C. The fixed cells were incubated for 12 h at
room temperature with a mouse monoclonal antibody (ap-
proximately 1.0 g/ml) against each of the following
KSHV-specific antigens: RTA (Nishimura et al., 2001),
ORF57 (K. Nishimura et al., submited for publication), K5
(Haque et al., 2000), K8, vIRF, ORF59, and K8.1 (Okuno et
al., 2002). After being washed three times with PBS con-
taining 0.05% Tween 20 for 5 min each, the slides were
air-dried and incubated with approximately diluted fluores-
cein isothiocyanate (FITC)-conjugated goat anti-mouse IgG
antibodies (DAKO) for 1 h. After being washed as de-
scribed above, the slides were mounted with 90% glycerol
in PBS and the signals were detected by fluorescence mi-
croscopy.
Western blotting
Whole-cell protein extract was prepared from RTA-in-
duced or uninduced cells at 12, 24, and 48 h after induction.
The protein concentration of the extracts was determined by
the Bradford assay. Samples (20 g) were subjected to
sodium dodecyl sulfate–7.5% polyacrylamide gel electro-
phoresis (SDS–PAGE) under reducing conditions and then
electrophoretically transferred to polyvinylidene difluoride
membranes (Bio-Rad) in 25 mM ethanolamine/NaOH (pH
Fig. 4. Generation of RTA-inducible BCBL-1 cells from replication-deficient BCBL-1 cells. (A) Immunofluorescence assay of KSHV lytic proteins.
Replication-deficient BCBL-1 clone (BCBL-1[L]) and BCBL-1 cells were fixed 48 h after TPA induction and labeled with an anti-vIRF or anti-K8.1 mouse
monoclonal antibody, respectively,followed by a fluorescein isothiocyanate-conjugated anti-mouse IgG. Original magnification, 400. (B) KSHV DNA
synthesis in replication-deficient BCBL-1 clone (BCBL-1[L]) and BCBL-1 cells. Cells were collected at the indicated times after TPA induction, and DNA
was extracted from the whole cells. Samples containing the same amount of DNA (5 g) were analyzed by Southern blotting using a probe specific for the
KSHV K8 region as described under Materials and methods. (C) RTA expression in BCBL-1/off  RTA-2 cells. Whole-cell extracts were obtained at
different times postinduction (Tc[]) and analyzed by Western blotting using a specific antibody against RTA. The same amount of total protein (20 g)
was loaded in each lane. The positions of molecular mass markers are shown on the left. The arrow indicates RTA protein.
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Fig. 5. The expression of KSHV lytic proteins in uninduced, RTA-induced, and TPA-induced BCBL-1/off RTA-2 cells. Cells were fixed 48 h postinduction
and labeled as indicated under Materials and methods with a mouse monoclonal antibody specific for the proteins indicated on the left of the photographs.
Original magnification, 100.
9.5). The membranes were blocked for 1 h while shaking
at room temperature in TBS (137 mM NaCl, 2.68 mM KCl,
25 mM Tris) containing 0.05% Tween 20 and 5% dry milk
and then incubated with either a mouse anti-RTA or a
mouse anti-PARP antibody (Kamiya Biomedical Co.) (the
former diluted in TBS–0.05% Tween 20 to 0.1 g/ml,
and the latter diluted to 0.5 g/ml) for 1 h with shaking at
room temperature. The membranes were then washed three
times for 5 min each in TBS–0.05% Tween 20 and incu-
bated for 1 h with shaking at room temperature with horse-
radish peroxidase conjugated donkey anti-mouse IgG
antibodies (1:5000 dilution) (Amersham Pharmacia Bio-
tech). After the membranes were washed, the signals
were detected using Super Signal West Pico Chemilumi-
nescent substrate (Pierce), according to the manufacturer’s
instructions.
Southern blotting
Approximately 1  107 of BCBL-1 and replication-
deficient BCBL-1 cells, untreated or treated with TPA, were
lysed in lysis buffer [150 mM NaCl, 10 mM Tris–HCl (pH
8.0), 10 mM EDTA, 0.1% SDS] supplemented with 100
g/ml proteinase K and incubated at 55°C for 1 h followed
by an overnight incubation at 37°C. Cell lysate was ex-
tracted twice with phenol/CHCl, and the DNA was precip-
itated in 70% ethanol. The DNA pellet was dissolved in TE
[10 mM Tris–HCl (pH 8.0), 1 mM EDTA (pH 8.0)], and
RNase A was added to a final concentration of 100 g/ml.
The samples were incubated at 37°C for 1 h; then the RNase
A was removed by phenol/CHCl3 extraction. The DNA was
then pelleted, dried, and dissolved in TE. DNA samples (5
g) were digested with BamHI, fractionated on a 1% aga-
rose gel, and transferred to a Hybond-N membrane under
denaturing conditions (0.4 M NaOH). The blots were UV
cross-linked using a UV Stratalinker 2400 (Stratagene) with
the standard protocol (120 mJ/cm2) and hybridized with
probes specific for the K8 region labeled by the random
prime labeling system (Amersham) with [-32P]dCTP (Am-
ersham), in hybridization buffer (6 SSC, 1% SDS, 100
g/ml sonicated salmon testis DNA, 1 mg/ml BSA, 1
mg/ml Ficoll 400, 1 mg/ml PVP360).
Detection of apoptosis
For the TUNEL assay, RTA-induced or uninduced cells
were washed, fixed, stained, and processed using the In Situ
Cell Death Detection Kit (Roche) as described by the man-
ufacturer. Annexin V and PI staining were performed on
RTA-induced or uninduced cells using the MEBCYTO-
Apoptosis Kit (MBL), according to the manufacturer’s in-
structions. The fluorescence of FITC and PI was detected by
FACScan (FACS Caliber, Becton Dickinson).
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